
Overview
Raed Al is a Hematologist in Westwood, Kansas. Dr. Al has been practicing medicine for over 28 years is highly rated in 23 conditions, according to our data. His top areas of expertise are Fibrolamellar Carcinoma, Neuroendocrine Tumor, Familial Colorectal Cancer, and Familial Pancreatic Cancer. Dr. Al is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2650 Shawnee Mission Parkway, Westwood, KS 66205
Kansas City Urology Care PA
Ajjai Alva is an Oncologist and a Hematologist in North Kansas City, Missouri. Dr. Alva is highly rated in 16 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Lymphadenectomy, and Nephrectomy. Dr. Alva is currently accepting new patients.
The University Of Kansas Health System - Clinical Research Center
Abdulraheem Yacoub is a Hematologist in Fairway, Kansas. Dr. Yacoub is highly rated in 51 conditions, according to our data. His top areas of expertise are Polycythemia Vera, Myelofibrosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Yacoub is currently accepting new patients.
AdventHealth Medical Group Hematology Oncology At Shawnee Mission
Jacob Smeltzer is a Hematologist and an Oncologist in Merriam, Kansas. Dr. Smeltzer is highly rated in 67 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Neuroendocrine Tumor, and Inflammatory Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cholangiocarcinoma (Bile Duct Cancer)
- Colorectal CancerDr. Al isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Al isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Al isDistinguished. Learn about Familial Pancreatic Cancer.
- Fibrolamellar CarcinomaDr. Al isDistinguished. Learn about Fibrolamellar Carcinoma.
- Lynch SyndromeDr. Al isDistinguished. Learn about Lynch Syndrome.
- Advanced
- Ampullary CancerDr. Al isAdvanced. Learn about Ampullary Cancer.
- Anal CancerDr. Al isAdvanced. Learn about Anal Cancer.
- Appendix CancerDr. Al isAdvanced. Learn about Appendix Cancer.
- Breast CancerDr. Al isAdvanced. Learn about Breast Cancer.
- Gallbladder Adenocarcinoma
- Gallbladder CancerDr. Al isAdvanced. Learn about Gallbladder Cancer.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Al isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Al isExperienced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Al isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer

